DK0669834T3 - Anvendelse af topisk påført faktor Xlll til inhibering af blødning - Google Patents

Anvendelse af topisk påført faktor Xlll til inhibering af blødning

Info

Publication number
DK0669834T3
DK0669834T3 DK94900578T DK94900578T DK0669834T3 DK 0669834 T3 DK0669834 T3 DK 0669834T3 DK 94900578 T DK94900578 T DK 94900578T DK 94900578 T DK94900578 T DK 94900578T DK 0669834 T3 DK0669834 T3 DK 0669834T3
Authority
DK
Denmark
Prior art keywords
factor xiii
topically applied
inhibit bleeding
applied factor
bleeding
Prior art date
Application number
DK94900578T
Other languages
Danish (da)
English (en)
Inventor
Marc R Mayberg
Martin William Edwards
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DK0669834T3 publication Critical patent/DK0669834T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
DK94900578T 1992-11-12 1993-11-09 Anvendelse af topisk påført faktor Xlll til inhibering af blødning DK0669834T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97502692A 1992-11-12 1992-11-12
PCT/US1993/010758 WO1994011022A1 (en) 1992-11-12 1993-11-09 Use of topically applied factor xiii for inhibiting hemorrhage

Publications (1)

Publication Number Publication Date
DK0669834T3 true DK0669834T3 (da) 2000-04-17

Family

ID=25522630

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94900578T DK0669834T3 (da) 1992-11-12 1993-11-09 Anvendelse af topisk påført faktor Xlll til inhibering af blødning

Country Status (9)

Country Link
EP (1) EP0669834B1 (el)
JP (1) JP2004231664A (el)
AT (1) ATE184199T1 (el)
CA (1) CA2149209C (el)
DE (1) DE69326349T2 (el)
DK (1) DK0669834T3 (el)
ES (1) ES2139729T3 (el)
GR (1) GR3031890T3 (el)
WO (1) WO1994011022A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07328108A (ja) * 1994-06-10 1995-12-19 Ajinomoto Co Inc 生体組織接着剤及び血液凝固剤
CA2438763A1 (en) * 2001-02-21 2002-09-06 Zymogenetics, Inc. Blood coagulation factor xiii for treating platelet disorders
WO2005115442A1 (en) * 2004-05-25 2005-12-08 Novo Nordisk Health Care Ag Use of coagulation factor xiii for treatment of post surgical bleedings
CN101010333B (zh) 2004-08-27 2013-08-14 诺和诺德医疗保健公司 从生物材料中纯化凝血因子xⅲ多肽
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
US20060093655A1 (en) 2004-10-20 2006-05-04 Lillian Bar Method for making a reinforced absorbable multilayered hemostatic wound dressing

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
AU2423988A (en) * 1987-08-17 1989-03-09 Liposome Company, Inc., The A sponge enzyme having transglutaminase-like activity
JPH01216939A (ja) * 1988-02-24 1989-08-30 Hoechst Japan Kk 末熟児頭蓋内出血阻止剤
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva

Also Published As

Publication number Publication date
DE69326349D1 (de) 1999-10-14
WO1994011022A1 (en) 1994-05-26
JP3884064B2 (ja) 2007-02-21
CA2149209A1 (en) 1994-05-26
ATE184199T1 (de) 1999-09-15
DE69326349T2 (de) 2000-03-02
ES2139729T3 (es) 2000-02-16
CA2149209C (en) 2000-08-01
GR3031890T3 (en) 2000-02-29
EP0669834B1 (en) 1999-09-08
JPH08505129A (ja) 1996-06-04
JP2004231664A (ja) 2004-08-19
EP0669834A1 (en) 1995-09-06

Similar Documents

Publication Publication Date Title
BR9708632A (pt) Composto calcilìticos
PT991619E (pt) Inibidores da adesao celular mediada pela alfa4beta1
FI941222A0 (fi) Ei-peptidyyli-tyyppisiä integriini-inhibiittoreita, jotka ovat spesifisiä GPIIbIIIa-reseptorin suhteen
FI973492A (fi) NO-syntaasin estäjät
DE60223262D1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
SE9701162D0 (sv) New use II
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
ATE245977T1 (de) Therapeutische substituierte guanidine
TR200100455T2 (tr) Nimesulid içeren topikal farmasötik bileşimler
DE60142632D1 (de) Heilung von wunden
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
DK0669834T3 (da) Anvendelse af topisk påført faktor Xlll til inhibering af blødning
ATE256392T1 (de) Verwendung von polyaminosäurederivate als konservierungsmittel
MX9505192A (es) Utilizacion de un antagonista de la substancia p para la obtencion de composiciones farmaceuticas para el tratamiento del enrojecimiento cutaneo de origen neurogenico.
NO984950L (no) Forbindelser med veksthormonfrigj°rende egenskaper
ES2140575T3 (es) L-lisil-glicil-l-histidina y agente terapeutico para curar heridas que lo contiene.
ATE310539T1 (de) Artikel zur wundbehandlung
SE9604744D0 (sv) A modified coagulation agent
BR0109896A (pt) Composição tópica em gel, curativo de feridas, seu método e uso
ATE302026T1 (de) Zusammensetzung enthaltend einen inhibitor der signaltransduktion von heterometrischen g proteinen in kombination mit einem antihypertensiven mittel zu einer therapeutischen verwendung in der behandlung von arterieller hypertonie
KR910700039A (ko) 탈모증 치료용의 미녹시딜 및 혈관수축제 조성물
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
YU42401A (sh) Supstituisani heterociklični acil-tripeptidi korisni kao modulatori receptora trombina
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung
ATE241640T1 (de) Fusidinsäure-derivate